-
Musk's empire as SpaceX counts down to Wall Street liftoff
-
SpaceX's IPO moonshot draws some doubters on Wall Street
-
Under Trump pressure, EU agrees to implement US trade pact
-
Republican who stood up to Trump defeated in Kentucky primary
-
Acting US attorney general defends fund for prosecuted Trump allies
-
Mavericks part ways with head coach Kidd
-
Shock and bafflement at San Diego mosque where three were killed
-
US enforces law to crack down on sexual deepfakes
-
Arsenal crowned Premier League champions after Man City draw
-
New York art auctions roar back with blockbuster sales
-
US says held talks with Cuba on $100 mln offer
-
Chelsea beat Spurs to leave rivals in 'embarrassing' relegation danger
-
Google wants its search bar to act on your behalf in AI revamp
-
Taiwan author wins International Booker for 'slyly sophisticated' novel
-
Iran 'very confident' about World Cup protocols: federation vice-president
-
Google unveils smart glasses, taking on Meta
-
Guardiola swerves Man City exit talk as title hopes ended
-
Chiefs' Rice jailed for probation violation
-
Five factors in Arsenal's Premier League title triumph
-
Mikel Arteta: Pep protege to Premier League winner
-
How Arsenal banished 'nearly men' tag to end 22-year title wait
-
Arsenal win Premier League after Man City held by Bournemouth
-
From graduation boos to voter unease: AI anxiety grows in the US
-
Lost in Trump's climate boast: best-case scenario abandoned
-
Hantavirus cruise operator says ship not source of outbreak
-
Trump shows off ballroom site with 'drone empire' planned for roof
-
Rubio to attend NATO talks, pay first visit to India
-
Under Trump pressure, EU seeks deal to end trade standoff
-
Airbus seeks to cut peripheral expenses due to Mideast war
-
France encourages women to report rape in probes of star Bruel
-
Guardiola silent on Man City exit reports
-
Argentine researchers collect rodents for hantavirus tests
-
Iran talks making 'good progress': US VP Vance
-
Teen wonder Sooryavanshi's slams 93 to edge Rajasthan closer to IPL play-offs
-
Norway reports Europe's first case of bird flu in a polar bear
-
Italy's Ganna wins time-trial in Giro shake-up
-
EU vows help for farmers hit by Iran war fertiliser price hikes
-
Emery focused on Villa glory, not crown of Europa League 'king'
-
French govt slams 'disproportionate' Canal+ riposte to anti-Bollore petition
-
US, Iran trade threats but Trump says Tehran wants peace deal
-
Russia's Zvyagintsev sets film amid 'disaster' Ukraine war
-
UK trade minister hopes Britain will rejoin EU 'in my lifetime'
-
Race to find vaccines, treatments for Ebola strain behind outbreak
-
King Charles III bangs drum for Irish music, eyes hip-hop lesson
-
Ganna wins time-trial in Giro shake-up
-
Drone attack kills 28 at market in southern Sudan
-
Putin lands in China for trip that aims to show unshakeable ties after Trump pomp
-
Israel finance minister says ICC seeks arrest warrant against him
-
Kentucky primary vote tests Trump's grip on Republican base
-
Alcaraz withdraws from Wimbledon with wrist injury
Warmer noses are better at fighting colds: study
Chilly weather and common respiratory infections often go hand in hand.
Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.
Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.
These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.
The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.
"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.
For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?
To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.
They found it did in fact produce EVs that target viruses.
In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.
These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.
Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.
But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.
"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.
"This is the first quantitative and biologically plausible explanation that has been developed."
One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.
"That's an area of great interest for us and we certainly continue to pursue that," he said.
C.Hamad--SF-PST